Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sympathetic nerve terminals innervating sweat glands are specialized postganglionic sympathetic neurons that, uniquely among sympathetic fibers, release acetylcholine, which acts on muscarinic receptors in eccrine sweat glands to induce sweating. This cholinergic mechanism is central to thermoregulatory sweating in humans[2][4][6][3]. Dysregulation or malfunction of these nerve terminals can cause sweating disorders such as hyperhidrosis or hypohidrosis. They are not themselves a drug target in the way that a specific protein or receptor would be, but the molecular targets they interact with (for example, muscarinic acetylcholine receptors or presynaptic proteins regulating neurotransmitter release) are established therapeutic targets for the treatment of sweating disorders[6][3][4].
Blockade of acetylcholine release (botulinum toxin); Muscarinic receptor antagonism (anticholinergics)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sympathetic nerve terminal innervating sweat gland.